logo
Best Stocks: A name that's a standout in its sector, with terrific fundamentals and nice chart set-up

Best Stocks: A name that's a standout in its sector, with terrific fundamentals and nice chart set-up

CNBC22-05-2025
(This is The Best Stocks in the Market , brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh: One sector that's been down and out for most of this year has been energy. These stocks have not participated. Many of the blue chip names in the space have completely missed out on the rally this spring. So I thought it might be interesting to look at some of the better stocks in the energy sector as a prelude to a possible rotation. It's been my experience that paying attention to good stocks in a bad segment of the market is a nice way to be positioned for when the group comes back into favor. I prefer this idea as opposed to focusing on the cheapest or the hardest hit names and hoping for a bounce. Both approaches may be valid and produce good results, but for the purposes of the Best Stocks concept, we're looking for strength, not weakness. The Best Stocks in the Market list currently has four energy stocks on it — two high-yield dividend plays and two companies with more growth characteristics. We'll show you all the charts below and put the spotlight on the one that looks like the most interesting set-up. Best Stock spotlight: EQT Corp. (EQT) Sean: The energy sector has struggled in 2025. It is down 1.6% year-to-date, tied with healthcare as the second worst sector this year. Only 35% of S & P 500 Energy constituents are above their 50-day moving average and an abysmal 30% of constituents are above their 200-day moving average. Both of those technical readings are the lowest readings of any sector. As Josh mentioned, taking a look at what's been working within a poorly performing sector can give us insight into the highest quality stocks within that area of the market. Those four energy stocks on our list are EQT Corp. (EQT) , Expand Energy (EXE) , Williams Cos. (WMB) , and Kinder Morgan (KMI) . Both EQT and EXE are the more growth oriented of the four. Both firms are natural gas-focused exploration and production companies. EQT is the best of the bunch with a 21% YTD return, making it the second best energy stock this year, and the 35th best S & P 500 stock in 2025. EQT is an independent natural gas production company with operations in the Marcellus and Utica shales, located in the Appalachian Basin. The company also has a joint venture with Blackstone. All of the firm's operating revenue is generated within the U.S., with most revenue flowing from the Marcellus Shale field and through the sale of natural gas. EQT has the second-highest expected EPS growth within S & P 500 Energy this year at 110% year-over-year EPS growth (just behind another stock on our list, EXE), and they expect 47% growth next year. What separates EQT from EXE (which we will hit next) is its profitability. EQT's operating margins are 17% while EXE's are 2%. EQT trades at a forward PE of 11x, all while ramping up its bottom line earnings. There's some institutional ownership here, too. As of Q1, big-name hedge funds like AQR, DE Shaw, and Millennium were ramping up ownership in the stock. It's a value stock acting like a momentum stock, which are great characteristics to have within a poorly performing sector. EXE has a good looking chart too: As of EXE's latest earnings call in April, it was the U.S.'s largest natural gas producer with holdings spanning 1.9 million acres. Free cash flow hit $533 million up from $131 million the previous year. EXE is also very well run. An entire portion of its earnings presentation is focused on a capital return framework. This includes a base dividend, an allocation of $500 million to pay down debt, plans to utilize additional free cash flow for variable dividends, and further balance sheet strengthening. The other two energy stocks on our list are WMB and KMI. Both of these firms are slower movers, operating midstream pipelines and refineries within the US. WMB has a dividend yield of 3.45% and KMI has a dividend yield of 4.25%. Both of these firms are holding up well in what's been a challenging environment for energy stocks, and they provide a bit more of a defensive posture relative to EXE and EQT. Risk Management Josh: What I like about the set-up for EQT is how well defined the risk is — the $50-$52 area had been resistance up until a month ago so it should become a support level in a rocky tape. So long as that level holds, I think you can be long. RSI in the low 60's confirms the recent retest of the highs but it is not at all overheated. Look for a high-volume breakout away from the $56 area as confirmation that the trade's going to work. DISCLOSURES: (None) All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY . THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. INVESTING INVOLVES RISK. EXAMPLES OF ANALYSIS CONTAINED IN THIS ARTICLE ARE ONLY EXAMPLES. THE VIEWS AND OPINIONS EXPRESSED ARE THOSE OF THE CONTRIBUTORS AND DO NOT NECESSARILY REFLECT THE OFFICIAL POLICY OR POSITION OF RITHOLTZ WEALTH MANAGEMENT, LLC. JOSH BROWN IS THE CEO OF RITHOLTZ WEALTH MANAGEMENT AND MAY MAINTAIN A SECURITY POSITION IN THE SECURITIES DISCUSSED. ASSUMPTIONS MADE WITHIN THE ANALYSIS ARE NOT REFLECTIVE OF THE POSITION OF RITHOLTZ WEALTH MANAGEMENT, LLC" TO THE END OF OR OUR DISCLOSURE. Click here for the full disclaimer.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Is This the Right Time to Consider Healthcare ETFs?
Is This the Right Time to Consider Healthcare ETFs?

Yahoo

time18 minutes ago

  • Yahoo

Is This the Right Time to Consider Healthcare ETFs?

U.S. healthcare stocks are currently trading at the biggest discount relative to the broader market in 30 years, according to Barrons, presenting a solid opportunity for investors looking for stability and potential growth. The Health Care Select Sector SPDR XLV, which mirrors the sector's performance, has fallen 9.6% over the past year while the broad SPDR S&P 500 ETF Trust SPY climbed about 16%. This has pushed healthcare stocks to trade at a historic valuation discount compared to the broader market. The sector has been struggling due to concerns over political and regulatory uncertainties, including government policies targeting prescription drug prices, tariffs on pharmaceuticals, and reduced funding in health research and Medicaid. The expiry of drug patents and setbacks faced by major companies have contributed to the sector's another sign of waning investor interest, healthcare ETFs have recorded 12 straight months of net outflows through July, totaling $11.5 billion. This represents the largest outflow of any sector, according to State Street Investment Management. Is the Sector Ready for a Rebound? The healthcare sector has gathered momentum with XLV gaining 4.2% over the past week versus a decline of 0.5% for SPY. This signals potential turnaround and came on the back of attractive valuation and growing hedge fund's exposure. Attractive Valuation The sector is currently trading at a forward P/E ratio of around 16, substantially lower than the S&P 500's P/E ratio of about 22 and far below technology's P/E ratio of 30. This discount is the widest seen in three decades, making healthcare stocks some of the most undervalued in the market relative to their earnings potential. Buffett Entry Provides A Major Boost Warren Buffett's Berkshire Hathaway investment in UnitedHealth UNH lifted sentiment, bolstering confidence in managed-care names. In the latest 13F filing, Berkshire Hathaway disclosed that it bought more than 5 million shares in UNH in the second quarter, valued at approximately $1.6 billion. The stock has soared more than 10% in a week (read: Insights Into 13F Filings: ETFs to Invest in Like Billionaires). Other Hedge Funds Increase Exposure Per the latest 13F filings, most hedge funds ramped up exposure to healthcare stocks. Stanley Druckenmiller, renowned investor and head of Duquesne Family Office, has increased his exposure to healthcare stocks as part of a strategic portfolio adjustment during the second quarter. His portfolio, valued at around $3.06 billion, shows a prominent tilt toward innovative healthcare and pharmaceuticals, reflecting his confidence in the sector's growth managers also highlighted exposure to Regeneron REGN and other life sciences names via both equity and calls, showing targeted science-driven bets. Corporate Action Stocks like CVS Health CVS gained on analyst upgrades. Novo Nordisk NVO surged following the FDA approval for a new use of its weight-loss drug (read: NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain). Rotation to Defensive Sectors Amid growing skepticism over lofty tech valuations, investors are shifting toward more stable, defensive sectors. This has helped healthcare stocks attract renewed attention as a safer haven. Healthcare generally outperforms during periods of low growth and high uncertainty, as evidenced in the current macro environment. AI and Technology Integration in Healthcare The emergence of AI-driven healthcare initiatives, such as the Stargate project, promised to revolutionize cancer research and healthcare technologies. This created optimism about innovation-led growth in the sector, attracting investments focused on AI and biotech companies advancing healthcare solutions. Solid Zacks Sector Rank The potential upside to the healthcare sector is confirmed by the Zacks Sector Rank in the top 44%, with about 75% of the industries ranking in the top 41%. This suggests that the momentum built up in the healthcare space lately will likely continue in the coming weeks. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report Novo Nordisk A/S (NVO) : Free Stock Analysis Report CVS Health Corporation (CVS) : Free Stock Analysis Report SPDR S&P 500 ETF (SPY): ETF Research Reports Health Care Select Sector SPDR ETF (XLV): ETF Research Reports This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Nvidia's Earnings Could Make Or Break Momentum ETFs
Nvidia's Earnings Could Make Or Break Momentum ETFs

Yahoo

time18 minutes ago

  • Yahoo

Nvidia's Earnings Could Make Or Break Momentum ETFs

A sudden tumble in the high-flying factor names could be paving the way for a reversal, say Goldman Sachs traders, putting the spotlight on ETFs tied to the factor ahead of NVIDIA Corp.'s (NASDAQ:NVDA) closely followed earnings next week. Nvidia's quarterly results could decide the fate of momentum stocks and the ETFs that track them, after a two-week slide put the high-flying trade under pressure. Nvidia is down more than 4% in the past week. Track its prices live, here. Goldman's High Beta Momentum basket, which bundles together the latest winners in the market and shorts losers, fell 13% from Aug 6 to Aug 19, its fourth drop of over 10% this year, as reported by Bloomberg. Historically, these sharp declines have tended to reverse rapidly from such a point. Goldman Sachs pointed out that in previous instances when the basket declined 10% or more in five days, it recovered during the next week, 80% of the time, with median returns of 4.5% during the next week and over 11% over the subsequent month. The ETF Angle Momentum-based ETFs such as the iShares MSCI USA Momentum Factor ETF (BATS:MTUM) and Invesco Dorsey Wright Momentum ETF (NASDAQ:PDP) offer investors direct exposure to the same high-octane growth stocks that dominate Goldman's basket, the likes of Nvidia, Advanced Micro Devices Inc (NASDAQ:AMD), and Palantir Technologies Inc (NASDAQ:PLTR). That makes the funds especially sensitive to whether Nvidia's earnings next week can revive enthusiasm in AI-related equities or deepen the selloff. ETFs that follow the momentum factor have also experienced uneven returns in 2025, with several abrupt swings related to the AI trade. The latest rout also questions whether these vehicles can be used as tactical trades or not long-term positions. What's Driving The Sell-off Losses in AI leaders such as Palantir, AMD, Super Micro Computer Inc (NASDAQ:SMCI), and even Nvidia, pulled the basket down. These formerly crowded trades now face profit-taking, high valuations, and nervousness about China's competitive squeeze. The Risk To Rebounds Although Goldman's traders point out that momentum has previously rebounded following steep drops, some warn that the factor has been erratic throughout the year. Bloomberg Intelligence's Christopher Cain said that high-momentum stocks have some of the most costly valuations relative to low momentum in history. The last catalyst will depend on Nvidia's earnings next week. As the heaviest weight in the S&P 500 and Nasdaq 100, the chipmaker's report could make or break whether momentum ETFs produce another record rebound — or this is merely the beginning of a more significant correction. Read Next: Photo: Chung-Hao-Lee via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? NVIDIA (NVDA): Free Stock Analysis Report This article Nvidia's Earnings Could Make Or Break Momentum ETFs originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Are Wall Street Analysts Bullish on Federal Realty Stock?
Are Wall Street Analysts Bullish on Federal Realty Stock?

Yahoo

time33 minutes ago

  • Yahoo

Are Wall Street Analysts Bullish on Federal Realty Stock?

Federal Realty Investment Trust (FRT), with a market cap of $8.3 billion, is a real estate company that owns, operates and redevelops high-quality retail-based properties located primarily in major coastal markets. The North Bethesda, Maryland-based company's retail properties are anchored by supermarkets, drugstores, or high-volume, value-oriented retailers, which provide essential 1consumer necessities. Shares of this retail REIT have underperformed the broader market over the past 52 weeks. FRT has declined 14.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 14.3%. Moreover, on a YTD basis, the stock is down 13.6%, compared to SPX's 9% rise. More News from Barchart As SoFi Launches International Money Transfer Services, How Should You Play SOFI Stock? This Cannabis Stock Just Transformed Into a Bitcoin Treasury Play. Should You Buy Shares Now? Profiting from Volatility: CRWV Long Straddle Trade Setup Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Narrowing the focus, FRT has also lagged behind the Real Estate Select Sector SPDR Fund's (XLRE) 1% uptick over the past 52 weeks and 2.5% return on a YTD basis. On Aug. 6, Federal Realty reported Q2 results that topped Wall Street expectations. Its funds from operations stood at $165.5 million, or $1.91 per share, beating the consensus estimate of $1.73 per share. Net income was $153.9 million, or $1.78 per share, while revenue came in at $311.5 million, slightly above forecasts of $310.7 million. The company projects full-year funds from operations in the range of $7.16 to $7.26 per share. Shares of the company declined marginally post the announcement. For the current fiscal year, ending in December, analysts expect FRT's FFO to grow 5.9% year over year to $7.17 per share. The company's FFO surprise history is mixed. It exceeded or met the consensus estimates in three of the last four quarters, while missing on another occasion. Among the 18 analysts covering the stock, the consensus rating is a 'Moderate Buy' which is based on nine 'Strong Buy,' one 'Moderate Buy,' and eight 'Hold' ratings. This configuration has been consistent for the past months. On Aug. 8, Evercore ISI analyst Steve Sakwa reaffirmed an 'Outperform' rating on Federal Realty Investment while slightly lowering the price target from $109 to $107, a 1.8% reduction. The mean price target of $107.50 represents an 11.2% premium from FRT's current price levels, while the Street-high price target of $115 suggests an upside potential of 18.9%. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store